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The Bcl-2 family protein Bax is a key effector of apoptosis. Lovell et al. (2008) now describe the 
reconstitution and regulation in liposomes of tBid-mediated membrane penetration and oligomer-
ization of Bax. These and other recent studies shed new light on the control of permeabilization of 
the mitochondrial outer membrane during apoptosis.Members of the Bcl-2 family constitute 
the critical effectors and regulators of 
programmed cell death or apoptosis 
(Youle and Strasser, 2008). In the face 
of stress stimuli, whether a cell survives 
or undergoes apoptosis is dependent on 
the extent of pairing between the Bcl-2 
family members that promote cell death 
with family members that promote cell 
survival. For the most part, these inter-
actions involve the docking of the Bcl-2 
homology 3 (BH3) domain of proapop-
totic family members into a groove on 
the surface of prosurvival members. 
Yet, how this translates into regulation of 
permeabilization of the outer mitochon-
drial membrane, a key element of the 
intrinsic pathway of apoptosis, has been 
challenging to decipher, and a number 
of conflicting results remain to be rec-
onciled (Youle and Strasser, 2008). In 
this issue, Lovell et al. (2008) report the 
reconstitution in liposomes of the series 
of dynamic events that lead to membrane 
permeabilization by the proapoptotic 
Bcl-2 proteins, tBid and Bax. They also 
provide insight into how a prosurvival 
Bcl-2 family member, Bcl-xL, antago-
nizes these events and how this antago-
nism is overcome by the proapoptotic 
member Bad.
The presence of Bcl-2 homology (BH) 
domains defines the membership of the 
Bcl-2 family, which is divided into three 
main groups depending upon the par-
ticular BH domains present within the 
protein. The prosurvival members such 
as Bcl-2, Bcl- xL, and Mcl-1 contain BH 
domains 1–4, whereas Bax and Bak 
the proapoptotic effectors of mitochon-
drial outer membrane permeabilization 1004 Cell 135, December 12, 2008 ©2008 E(MOMP) during apoptosis, contain BH 
domains 1–3. A larger group of proapop-
totic members, including Bid, Bim, and 
Bad, among others, contain only the BH3 
domain and serve to couple upstream 
stress stimuli to downstream modulation 
of the multi-BH domain members.
There are two important factors that 
have contributed to the challenge of 
understanding how interactions between 
Bcl-2 family members regulate mem-
brane permeabilization. First, the mem-
brane appears to play an active role in 
modulating Bcl-2 family protein struc-
ture, interactions, and function. Sec-
ond, stress stimuli can lead to dynamic 
changes in protein conformation, cul-
minating in the penetration of otherwise 
cytosolic domains into the lipid bilayer, 
where the relevant protein-protein inter-
actions take place (Annis et al., 2005; 
Dlugosz et al., 2006; Billen et al. 2008). 
This makes it particularly difficult to elu-
cidate valid interactions between the 
Bcl-2 members with cell-based assays 
in which membranes are destroyed.
In unstressed cells, Bax resides inert in 
the cytosol, probably because of the fact 
that its C-terminal membrane anchor is 
sequestered within the hydrophobic sur-
face groove (Suzuki et al., 2000). Changes 
at the extreme N terminus, on the other 
hand, can derepress the sequestered 
membrane anchor, resulting in insertion 
of the protein into its target membranes, 
the mitochondrial outer membrane, and 
the endoplasmic reticulum (Goping et 
al., 1998). At the membrane, Bax under-
goes a dramatic conformational change 
caused by the insertion of helices 5 and 
6 into the bilayer (Annis et al., 2005), and lsevier Inc.it is this conformer that oligomerizes. 
Bax then assumes a structure reminis-
cent of the pore-forming colicins and 
diptheria toxins. The bilayer, therefore, is 
not simply a barrier that Bax can breach 
but is an active participant in the initial 
activation of Bax (and likely explains why 
functional reconstitution in liposomes is 
possible).
What initiates the physiological acti-
vation of Bax? One model suggests 
that the active forms of certain BH3-
only proteins (tBid, Bim, and potentially 
Puma) interact with Bax, seeding the 
cascade of Bax transformations (Youle 
and Strasser, 2008; Letai et al., 2002). 
However, what has been missing until 
now is the geographic and kinetic eluci-
dation of this interaction. Employing an 
amphiphilic BH3 peptide derived from 
Bim, which is locked into its functional 
conformation, Gavathiotis et al. (2008) 
have recently found a noncanonical BH3 
binding site located near the N terminus 
of Bax. It is on the opposite face of the 
protein from the canonical BH3 binding 
site of the antiapoptotic members. It is 
attractive to speculate that this bind-
ing provides the physiological stimulus 
to cause the N-terminal changes that 
induce derepression of the membrane 
anchor, leading to membrane insertion 
and activation of Bax. Other non-BH3 
stimuli such as heat and pH might mimic 
these Bim-induced changes at the N ter-
minus.
The liposome reconstitution experi-
ments of Lovell et al. (2008), presented in 
this issue, add important further support 
for this model. The authors employed 
fluorescence resonance energy transfer 
Figure 1. Regulation of Membrane Permeabilization by Bcl-2 Family Proteins
(A) Cleavage by caspase-8 generates tBid (orange), which rapidly migrates to the membrane (Lovell et al., 
2008), where its BH3 domain (red) seeds the insertion of Bax (blue) into the membrane via binding to a non-
canonical BH3 binding site near the N terminus of Bax (Gavathiotis et al., 2008). The resulting activated Bax 
molecules can now oligomerize both between themselves and by recruiting inactive Bax conformers from 
the cytosol, resulting in membrane permeabilization (Dlugosz et al., 2006, Billen et al., 2008).
(B) Bcl-xL (green) in excess competes with Bax to interact with tBid, but, unlike the binding of the tBid 
BH3 domain to the N terminus of Bax, the canonical interaction of tBid with the BH3 binding groove of 
Bcl-xL is relatively stable. Similarly, Bcl-xL can interact with the exposed BH3 of the activated conformer 
of Bax, forming nonproductive dimers that cannot oligomerize. Thus Bcl-xL has at least two ways of 
inhibiting Bax oligomerization (Dlugosz et al., 2006; Billen et al., 2008; Lovell et al., 2008).
(C) A “sensitizing” BH3-only protein Bad (purple) can displace tBid or activated Bax from sequestration 
by Bcl-xL (Billen et al., 2008; Letai et al., 2002; Lovell et al., 2008), freeing tBid to seed the activation of 
additional Bax molecules, leading to Bax-mediated membrane permeabilization.(FRET) to measure, both in real time and 
simultaneously in a single reaction, protein 
movement, interactions between binding 
partners, and penetration of Bcl-2 family 
proteins into the bilayer. They find that tBid 
migrates and inserts into the liposome very 
quickly and is required for Bax activation. 
Consequently, it initiates Bax activation at 
the membrane, coupling this activation to 
the slower kinetics of membrane insertion 
of Bax into the bilayer. Thus, tBid appears 
to act like an essential membrane receptor 
for membrane permeabilization mediated 
by Bax (Figure 1), that is, at least in this 
simplified system free of influences that 
might otherwise occur in an intact cell.The studies of Lovell et al. also address 
the current controversies around the 
mechanisms of antagonism of Bax-
mediated membrane permeabilization by 
prosurvival Bcl-2 proteins. The prosur-
vival proteins Bcl-2 and Bcl-xL, at least in 
reconstituted membranes in vitro, exhibit 
remarkable similarities to Bax in almost all 
respects, including the ability to undergo 
conformational alterations and penetration 
into the bilayer of helices 5 and 6 (Dlugosz 
et al., 2006; Billen et al., 2008). An impor-
tant exception is that dimers between 
activated conformers of Bcl-2 or Bcl-xL 
and Bax, in contrast to activated Bax 
itself, cannot further oligomerize within the Cell 135, Debilayer and therefore represents a dead 
end interaction (Billen et al., 2008) (Figure 
1). In theory, Bcl-2/Bcl-xL antagonism of 
Bax could operate at multiple steps in the 
Bax activation pathway, although certain 
models put forth mutually exclusive expla-
nations (Youle and Strasser, 2008; Letai 
et al., 2002; Willis et al., 2007). One model 
favors sequestration by Bcl-2/Bcl-xL of 
BH3-only proteins that directly activate 
Bax, with other “sensitizing” BH3-only 
proteins (such as Bad, which does not 
interact with Bax) having the capacity to 
displace the sequestered activator BH3, 
freeing it to go on to activate Bax (Letai et 
al., 2002). Another model favors the pos-
sibility that the antagonism of Bax stems 
exclusively from the constitutive interac-
tion of Bax with Bcl-2 or Bcl-xL. Displace-
ment of Bax by a BH3-only protein initi-
ates the Bax activation cascade by an as 
yet undetermined mechanism (Willis et al., 
2007). Based on the new evidence in favor 
of activating BH3-only proteins, elements 
of the latter model may kick in downstream 
of Bax activation (by BH3-dependent or 
-independent means) (Figure 1). The direct 
model, if correct, assumes that Bcl-2 and 
Bcl-xL represent a massive sink for inter-
action with activator BH3-only proteins 
relative to binding to Bax. This implies a 
significantly higher binding affinity to acti-
vator BH3-only proteins, a requirement for 
a significant excess of Bcl-2 and Bcl-xL 
relative to Bax, and/or kinetics that favor 
the differential appearance of competing 
binding partners at the membrane sur-
face.
The FRET analyses of Lovell et al. 
(2008) support the notion that Bcl-xL can 
effectively sequester almost the entire 
population of tBid molecules, with a 
smaller amount of membrane-integrated 
Bcl-xL/Bax dimers also detected. Bad 
in excess over tBid (10×) displaced tBid, 
which subsequently activated Bax (Fig-
ure 1). It should be emphasized, however, 
that both the order of addition of Bcl-xL 
to liposomes (which preceded tBid) and 
the relatively modest excess of Bcl-xL 
relative to tBid (2×) likely influenced the 
preferred choice of binding partners in 
this system. It would be intriguing to sys-
tematically analyze this.
Notwithstanding the numerous sec-
ondary elements of control over Bcl-2 
family protein-protein interactions that 
exist within an intact cell (Youle and cember 12, 2008 ©2008 Elsevier Inc. 1005
Strasser, 2008), the liposome reconsti-
tution system developed by Lovell et al. 
(2008) represents a powerful biochemical 
means to investigate the dynamic behav-
ior of Bcl-2 proteins in intact membranes. 
In the cell, multiple members of the three 
Bcl-2 subgroups are typically expressed. 
Unlike Bcl-xL and Bax, several of these 
(Bcl-2, Mcl-1, and Bak) are constitutively 
tethered to the mitochondrial outer mem-
brane via their transmembrane segments 
prior to activation. The similarities and dif-
ferences of the interactions between dif-
ferent Bcl-2 binding partners at the mem-
brane, and their influence on membrane 
permeabilization, can now be explored.1006 Cell 135, December 12, 2008 ©2008 E
The study of hematopoiesis has been 
remarkably fruitful for uncovering basic 
principles of tissue organization including 
lineage hierarchy and in understanding 
how organismal outcomes are affected 
by the responses of specific cell types. 
An example is host defense, where the 
blood is remarkably nimble at shifting 
its production of cells into high gear 
when challenged with infection or bleed-
ing. Although hematopoietic stem cells 
(HSCs) ultimately make this response 
possible, the majority of cell production 
occurs in a more mature population, the 
progenitor cells. However, these cells 
have little capacity for self-renewal and 
are therefore rightly designated transient 
amplifying cells. Consequently, the stem 
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cell must be feeding cells into the self-
depleting progenitor pool on an ongoing 
basis, which would require some degree 
of HSC proliferation. Yet, if the stem cell 
pool is mitotically active, even if at a rate 
far below that of the transient amplifying 
pool, the cells would likely be suscep-
tible to genotoxic injury and subsequent 
apoptosis. If so, HSCs might fail to pre-
serve the regenerative pool necessary to 
overcome a hematopoietic crisis created 
by prolonged genotoxic stress. It has 
been unclear how a single population 
of stem cells reconciles these two com-
peting duties, that is, supplying transit-
amplifying cells while maintaining a 
deep reserve of stem cells for long-term 
repopulation. As a potential resolution 
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even within a given tissue, may represent 
a spectrum of cells with heterogeneous 
capabilities.
Although murine HSCs do have a lower 
rate of cell cycling compared to progeni-
tor pools, it has been shown that their cell 
cycling frequency is surprisingly rapid, 
with 6%–8% of HSCs entering cycle daily 
(Cheshier et al., 1999; Kiel et al., 2007). 
In addition, recent efforts have defined 
mammalian intestinal and hair follicle cell 
pools with convincing stem cell features 
that are actively cycling (Barker et al., 
2007; Jaks et al., 2007). Small intestinal 
stem cells are estimated to turn over 
daily, for example (Barker et al., 2007). 
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